Stocks and InvestingStocks and Investing
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022
Mon, December 19, 2022

Joseph Pantginis Maintained (ATXS) at Strong Buy with Increased Target to $20 on, Dec 19th, 2022


Published on 2024-10-28 00:38:28 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Astria Therapeutics, Inc." (ATXS) at Strong Buy with Increased Target from $13 to $20 on, Dec 19th, 2022.

Joseph, nor any peers, have made any analyst calls on ATXS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30